Advanced lung cancer patients’ use of egfr tyrosine kinase inhibitors and overall survival: real-world evidence from quebec, canada

HIGHLIGHTS

• who: Samia Qureshi et al. from the Quebec, Canada McGill University, Montreal, QC H A , Canada have published the paper: Advanced Lung Cancer Patientsu2019 Use of EGFR Tyrosine Kinase Inhibitors and Overall Survival: Real-World Evidence from Quebec, Canada, in the Journal: (JOURNAL) of 31/03/2019
• what: The aim was to compare overall survival (OS) among patients receiving these treatments to those in previous experimental and real-world studies.
• how: For all cohorts the authors selected patients who had their first lung cancer diagnostic code in MED-ECHO or SMOD between 1 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.